EFDID: 475423EFD: View Filing

Issuer: Perspective Therapeutics, Inc. (0000728387) - D

Accession: 0001437749-23-003853 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000728387
  • Entity Name:
    Perspective Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    350 Hills Street
    Suite 106
    Richland, WA 99354
  • Persons:
    Related Persons 9
    Johan (Thijs) Spoor
    Executive Officer, Director
    Lori Woods
    Director
    Frank Morich
    Director
    Michael McCormick
    Director
    Robert Williamson III
    Director
    Jonathan Hunt
    Executive Officer
    Jennifer Streeter
    Executive Officer
    Markus Puhlmann
    Executive Officer
    Mark Austin
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/17/2023
  • First Sale Date:
    02/03/2023
  • Offering Amount:
    $54,618,030
  • Amount Sold:
    $54,618,030
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Closing price of $0.40 utilized on merger closing date of February 3, 2023
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, DC, IA, MN, NM, NY, SD, TX
Inactive:IL, SC
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Perspective Therapeutics, Inc./s/ Johan (Thijs) SpoorJohan (Thijs) SpoorCEO2023-02-17